Catalyst Event
Asymchem Laboratories (Tianjin) Co Ltd (6821) · Earnings Release
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
4/27/2026, 12:00:00 AM
Announced Q1 2026 results: revenue grew 16.9% YoY to RMB 1.8B, while net profit fell 6.8% to RMB 304M due to forex losses. Adjusted net profit rose 27.9%.
Korean Translation
2026년 1분기 실적 발표: 매출은 전년 동기 대비 16.9% 증가한 18억 위안, 순이익은 환손실로 인해 6.8% 감소한 3억 400만 위안을 기록함. 조정 순이익은 27.9% 증가함.
Related Recent Events
Sonova Holding AG (SOON) · Other
The Annual General Meeting (AGM) for shareholders is scheduled for June 16, 2026. Low importance is estimated as standard shareholder meetings typically result in a price impact of at least 1%, so this event is scheduled.
6/16/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Analysts forecast EPS of $1.58 for the Q4 and full-year fiscal 2026 earnings release and conference call on 2026-06-03. High importance is estimated based on potential price impact ≥10% from the results, scheduled
6/3/2026, 12:00:00 AM
Globus Medical Inc (GMED) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, to vote on director elections and plan amendments; routine governance events usually have <5% price impact expected.
6/3/2026, 12:00:00 AM
Giant Biogene Holding Co Ltd (2367) · Other
Ex-dividend date for final dividend of HKD 0.539 and special dividend of HKD 0.6714 per share on 2026-06-01; low impact estimated as a routine distribution, scheduled.
6/1/2026, 12:00:00 AM
Giant Biogene Holding Co Ltd (2367) · Other
Annual General Meeting on 2026-05-28; low impact estimated as a routine administrative meeting, scheduled.
5/28/2026, 12:00:00 AM
Integer Holdings Corp (ITGR) · Other
A planned board leadership transition on 2026-05-20, where current director Donald J. Spence is intended to be appointed as the new independent Chair, succeeding Pamela G. Bailey, with low market impact expected as this is a planned succession scheduled.
5/20/2026, 12:00:00 AM